es102
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 26, 2021 (NCT04730843)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06623136 | Phase 2 | Oct 9, 2024 | Elpiscience (Suzhou) Biopharma, Ltd. |
| NCT04991506 | Phase 1 | Oct 15, 2021 | Elpiscience Biopharma, Ltd., Shanghai Junshi Bioscience Co.,Ltd. |
| NCT04730843 | Phase 1 | Mar 26, 2021 | Elpiscience Biopharma, Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Elpiscience Biopharma, Ltd. | For profit | 2 | 2 | 1 | 2021 |
| Elpiscience (Suzhou) Biopharma, Ltd. | For profit | 1 | 1 | 1 | 2024 |
| Shanghai Junshi Bioscience Co.,Ltd. | For profit | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1